Siemer, S.; Fauth, T.; Scholz, P.; Al-Zamel, Y.; Khamis, A.; Gül, D.; Freudelsperger, L.; Wollenberg, B.; Becker, S.; Stauber, R.H.;
et al. Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance. Cancers 2021, 13, 4831.
https://doi.org/10.3390/cancers13194831
AMA Style
Siemer S, Fauth T, Scholz P, Al-Zamel Y, Khamis A, Gül D, Freudelsperger L, Wollenberg B, Becker S, Stauber RH,
et al. Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance. Cancers. 2021; 13(19):4831.
https://doi.org/10.3390/cancers13194831
Chicago/Turabian Style
Siemer, Svenja, Torsten Fauth, Paul Scholz, Yara Al-Zamel, Aya Khamis, Désirée Gül, Laura Freudelsperger, Barbara Wollenberg, Sven Becker, Roland H. Stauber,
and et al. 2021. "Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance" Cancers 13, no. 19: 4831.
https://doi.org/10.3390/cancers13194831
APA Style
Siemer, S., Fauth, T., Scholz, P., Al-Zamel, Y., Khamis, A., Gül, D., Freudelsperger, L., Wollenberg, B., Becker, S., Stauber, R. H., & Hagemann, J.
(2021). Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance. Cancers, 13(19), 4831.
https://doi.org/10.3390/cancers13194831